A new study indicates medical cannabis use among women in the USA to manage menopause-related symptoms is increasing. In the study, 250 perimenopausal and postmenopausal women recruited through advertising targeted to women interested in women’s health and cannabis or cannabinoids were assessed. The split between perimenopausal and postmenopausal women  was...
Fiji's hemp industry can finally soon get under way after recent passing of legislation. Fiji President Wiliame Katonivere will be pretty pleased after the Illicit Drugs Control (Budget Amendment) Bill 2022, which sought to amend the Illicit Drugs Control Act 2004,  passed muster in Fiji's Parliament in late July. Among the...
An Australian pilot study indicates cannabidiol (CBD) may have a role to play in addressing chronic anxiety in youth. Anxiety is the most common form of mental ill-health in young Australians, impacting 31.5 per cent of those aged 16–24 according to the Australian Bureau of Statistics – that's almost double...
A two-year moratorium on applications for new medical marijuana grower, dispensary and processor licenses in Oklahoma kicks in later this month - for real this time. The state's medical marijuana industry has been going gangbusters, and this has created a number of challenges for the Oklahoma Medical Marijuana Authority (OMMA)...
Australian cannabis company Creso Pharma Limited (ASX:CPH) is looking to acquire an international pharmaceutical distributor specialising in the distribution of medicinal cannabis products. Creso Pharma announced last week it had inked a non-binding term sheet to acquire Health House International Ltd (ASX: HHI). The acquisition is conditional on completion...
Ananda Scientific has announced the first patient enrolled in its clinical trial evaluating a cannabidiol-based drug as an adjunctive treatment for Opioid Use Disorder. The Colorado-headquartered company  received approval from the FDA for the trial in January this year. The drug involved is Ananda's Nantheia ATL5; an investigational drug based...
A report from the Canadian Government's Science Advisory Committee on health products containing cannabis has provide recommendations on the use of non-prescription CBD. Health Canada tasked the Committee to provide advice that would help inform development of regulations. The Committee noted the volume of scientific publications has increased exponentially over the...
A new report indicates the potential future impact of the USA's CBD industry being left in limbo with regard to Food and Drug Administration (FDA) regulations. While cannabidiol (CBD) has been legal in the USA since the signing of the 2018 Farm Bill into law, the FDA is yet to...
The Medicines Control Authority of Zimbabwe is now accepting applications for approval of hemp-based cannabidiol products as complimentary medicines. The MCAZ is tasked with ensuring medicines, allied substances and medical devices are safe, effective and of good quality. One of its slogans is "protecting your right to human medicines and...
Johns Hopkins Medicine researchers' findings after studying more than 100 over-the-counter topical cannabidiol (CBD) products are rather unsettling. It won't come as earth-breaking news that many CBD products available in the USA don't contain what they say on their labels. But the fact that it's continuing after so much media...